BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
申请人:Braje Wilfried Martin
公开号:US20090131452A1
公开(公告)日:2009-05-21
The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I′ and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT
6
receptor.
wherein
R
1
is hydrogen or methyl
R
2
is hydrogen or methyl
R
3
hydrogen, fluorine C
1
-C
2
alkoxy or fluorinated C
1
-C
2
alkoxy;
R
4
is hydrogen, C
1
-C
4
alkyl or fluorinated C
1
-C
4
alkyl;
R
5
is hydrogen, fluorine, C
1
-C
2
alkyl fluorinated C
1
-C
2
alkyl C
1
-C
2
alkoxy or fluorinated C
1
-C
2
alkoxy; and
R
6
is hydrogen, fluorine or chlorine.
Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
申请人:Abbott GmbH & Co. KG
公开号:US07790727B2
公开(公告)日:2010-09-07
The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I′ and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor.
wherein
R1 is hydrogen or methyl
R2 is hydrogen or methyl
R3 hydrogen, fluorine C1-C2 alkoxy or fluorinated C1-C2 alkoxy;
R4 is hydrogen, C1-C4 alkyl or fluorinated C1-C4 alkyl;
R5 is hydrogen, fluorine, C1-C2 alkyl, fluorinated C1-C2 alkyl, C1-C2 alkoxy or fluorinated C1-C2 alkoxy; and
R6 is hydrogen, fluorine or chlorine.
[EN] BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR<br/>[FR] COMPOSÉS DE BENZÈNESULFONANILIDE ADAPTÉS AU TRAITEMENT DE TROUBLES RÉPONDANT À LA MODULATION DU RÉCEPTEUR SÉROTONINERGIQUE 5-HT6
申请人:ABBOTT GMBH & CO KG
公开号:WO2009056632A1
公开(公告)日:2009-05-07
The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I' and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT6 receptor. wherein R1 is hydrogen or methyl R2 is hydrogen or methyl R3 hydrogen, fluorine C1-C2 alkoxy or fluorinated C1-C2 alkoxy; R4 is hydrogen, C1-C4 alkyl or fluorinated C1-C4 alkyl; R5 is hydrogen, fluorine, C1-C2 alkyl, fluorinated C1-C2 alkyl, C1-C2 alkoxy or fluorinated C1-C2 alkoxy; and R6 is hydrogen, fluorine or chlorine.